Clinical Trial Update: Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study of dalfampridine combined with physical therapy for mobility impairment in multiple sclerosis, which is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Dalfampridine (dalfampridine)

Snippet

Sponsor: MGH Institute of Health Professions | Conditions: Multiple Sclerosis | Phase 4 | Status: RECRUITING